We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Outcome prediction by amplitude-integrated EEG in adults with hypoxic ischemic encephalopathy.
Clinical Neurology and Neurosurgery 2012 July
INTRODUCTION: Amplitude-integrated electroencephalography (aEEG) had been widely used in predicting outcome in infants with hypoxic ischemic encephalopathy (HIE). We aimed to evaluate the use of aEEG as a quantitative predictor of outcome in adult patients with HIE.
METHODS: aEEG and Glasgow coma scale (GCS) were recorded for patients with HIE within 72 h of onset. aEEG traces were categorized as Grade I (normal amplitude): upper margin of aEEG activity >10 μV, lower margin >5 μV; Grade II (moderately abnormal amplitude): upper margin of aEEG activity >10 μV, lower margin ≤5 μV, or with suppressed amplitude, upper margin ≤10 μV, lower margin >5μV; Grade III (mild abnormality): either upper margin <10 μV, lower margin <5 μV. GCS was graded as I (9-14), grade II (4-8), or grade III (3). Cerebral performance category scores (CPCs) were determined 1 and 3 month after clinical evolution. CPC 1,2 were defined as favorable outcome; CPC 3,4,5 were considered as poor outcome.
RESULTS: 30 cases met inclusion criteria. Both the aEEG grade and GCS scores correlated significantly with short-term outcome, and cases with a worse aEEG grade were more likely to have an unfavorable short-term outcome. Since the number of patients is really too small for long-term outcome analysis, we did not perform the analysis of aEEG, GCS and longer-term outcome. There was significant difference of clinical findings among aEEG classifications, while no statistical difference was found of causes of HIE.
CONCLUSIONS: aEEG is a reliable predictor of short-term outcome in HIE, and aEEG results within 72h after onset were associated with neurodevelopmental outcome at 1 mo following clinical evolution.
METHODS: aEEG and Glasgow coma scale (GCS) were recorded for patients with HIE within 72 h of onset. aEEG traces were categorized as Grade I (normal amplitude): upper margin of aEEG activity >10 μV, lower margin >5 μV; Grade II (moderately abnormal amplitude): upper margin of aEEG activity >10 μV, lower margin ≤5 μV, or with suppressed amplitude, upper margin ≤10 μV, lower margin >5μV; Grade III (mild abnormality): either upper margin <10 μV, lower margin <5 μV. GCS was graded as I (9-14), grade II (4-8), or grade III (3). Cerebral performance category scores (CPCs) were determined 1 and 3 month after clinical evolution. CPC 1,2 were defined as favorable outcome; CPC 3,4,5 were considered as poor outcome.
RESULTS: 30 cases met inclusion criteria. Both the aEEG grade and GCS scores correlated significantly with short-term outcome, and cases with a worse aEEG grade were more likely to have an unfavorable short-term outcome. Since the number of patients is really too small for long-term outcome analysis, we did not perform the analysis of aEEG, GCS and longer-term outcome. There was significant difference of clinical findings among aEEG classifications, while no statistical difference was found of causes of HIE.
CONCLUSIONS: aEEG is a reliable predictor of short-term outcome in HIE, and aEEG results within 72h after onset were associated with neurodevelopmental outcome at 1 mo following clinical evolution.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app